Bone Marrow

Stem Cell Procedure

022416_TreatmentImages_Bone Marrow


By using bone marrow to harvest stem cells, patients have the opportunity to breathe easier. This two-part outpatient procedure is minimally invasive and is completed over the course of two days. Each day will require several hours in our office where the stem cells will be harvested, processed and separated and then reintroduced into your body. After reintroduction, the stem cells may begin to promote healing.

Why Choose Bone Marrow?

Bone marrow contains a much greater number of adult stem cells than found in peripheral blood. The amount of stem cells harvested from a bone marrow procedure have proven to result in a high patient success rate and a significant improvement on patient quality of life. Now, patients that have previously only qualified for the venous procedure are eligible for the bone marrow treatment.

Bone Marrow Stem Cell Procedure

The bone marrow procedure is a hybrid treatment that takes place over the course of two days in a clinical outpatient setting. Before treatment can begin, the patient must complete all bloodwork, paperwork and prerequisite testing, which typically includes an electrocardiogram (EKG) and a pulmonary function test. After this necessary evaluation, the patient can visit one of our state-of-the-art clinics to begin treatment.

For the next couple of days, the patient will spend a few hours in the clinic each day. The first day of treatment consists of the bone marrow aspiration, which removes a small amount of bone marrow fluid. On the second day of treatment, the patient will receive the venous procedure, which uses an IV to collect a blood sample. Each day, the clinicians will harvest, process and separate and then return the stem cells from the blood or bone marrow to the patient intravenously. After reintroduction, the stem cells may begin to promote healing.

Patients are often surprised by the simplicity of these minimally invasive procedures, but with cutting-edge technology and a patient-centric clinical team, patients can rest assured that they are in good hands. Throughout the entire treatment process, patients have the opportunity to get any questions immediately answered by our knowledgeable medical staff. The Lung Institute clinical team remains in contact with patients after treatment and works together with the patient’s physician and pulmonologist to create a strong support system for the patient.

Follow-Up Care

On the second and last day of treatment, a Lung Institute clinician will assess the patient for discharge and outline what the next few weeks will look like in terms of follow-up care. Generally, the patient will receive follow-up care at two weeks, three months and six months following his or her treatment. The patient is encouraged to return for a follow-up appointment with his or her pulmonologist at his or her three-month mark. At any time post-treatment, patients are welcome to contact their Patient Coordinator with questions and status updates.

Related Posts

  • Is Silicosis Fatal?Yes, silicosis can be fatal. This respiratory disease is caused by inhaling crystalline silica dust, which produces inflammation and scarring when it settles into the lungs. As time passes, this ... Read more
  • How Does Emphysema Affect Lung Function?Emphysema affects lung function in three main ways. First, emphysema causes holes to gradually form inside the lungs’ air sacs, thereby weakening their internal structure and inhibiting the exchange of ... Read more

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.